These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3533 related items for PubMed ID: 11109974

  • 1. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 2. Adrenal function under long-term raloxifene administration.
    Genazzani AR, Lombardi I, Borgioli G, di Bono I, Casarosa E, Gambacciani M, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
    [Abstract] [Full Text] [Related]

  • 3. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

  • 4. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N, Ninni F, Stomati M, Freschi L, Casarosa E, Valentino V, Luisi S, Genazzani AD, Potì E, Genazzani AR.
    Maturitas; 2008 Apr 20; 59(4):293-303. PubMed ID: 18394829
    [Abstract] [Full Text] [Related]

  • 5. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
    Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR.
    Gynecol Endocrinol; 1999 Feb 20; 13(1):15-25. PubMed ID: 10368794
    [Abstract] [Full Text] [Related]

  • 6. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR.
    Fertil Steril; 2003 Dec 20; 80(6):1495-501. PubMed ID: 14667889
    [Abstract] [Full Text] [Related]

  • 7. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 20; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 8. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Mar 20; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

  • 9. [Defects of adrenal steroidogenesis in patients with hirsutism].
    Salinas Vert I, Audí Parera L, Granada Ybern ML, Lucas Martín A, Pizarro Lozano E, Foz Sala M, Sanmartí Sala A.
    Med Clin (Barc); 1998 Feb 14; 110(5):171-6. PubMed ID: 9547720
    [Abstract] [Full Text] [Related]

  • 10. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
    Abraham GE, Maroulis GB.
    Obstet Gynecol; 1975 Mar 14; 45(3):271-4. PubMed ID: 163457
    [Abstract] [Full Text] [Related]

  • 11. Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency.
    Genazzani AR, Inglese S, Lombardi I, Pieri M, Bernardi F, Genazzani AD, Rovati L, Luisi M.
    Aging Male; 2004 Jun 14; 7(2):133-43. PubMed ID: 15672938
    [Abstract] [Full Text] [Related]

  • 12. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ, O'Keane V, Miell JP.
    Psychoneuroendocrinology; 2004 Jul 14; 29(6):724-32. PubMed ID: 15110921
    [Abstract] [Full Text] [Related]

  • 13. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
    Hampl R, Snajderova M, Lebl J, Lisa L, Dvorakova M, Hill M, Sulcova J, Starka L.
    Endocr Regul; 2001 Mar 14; 35(1):17-24. PubMed ID: 11308992
    [Abstract] [Full Text] [Related]

  • 14. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH, Härle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T, Nishimoto N.
    Arthritis Rheum; 2006 Jun 14; 54(6):1778-85. PubMed ID: 16729287
    [Abstract] [Full Text] [Related]

  • 15. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep 14; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 16. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
    Bernardi F, Pieri M, Stomati M, Luisi S, Palumbo M, Pluchino N, Ceccarelli C, Genazzani AR.
    Gynecol Endocrinol; 2003 Feb 14; 17(1):65-77. PubMed ID: 12724021
    [Abstract] [Full Text] [Related]

  • 17. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
    Maroulis GB, Abraham GE.
    Obstet Gynecol; 1976 Aug 14; 48(2):150-4. PubMed ID: 133306
    [Abstract] [Full Text] [Related]

  • 18. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK, Zhang SF, Zou SE, Xia X, Xu LN.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct 14; 48(10):740-4. PubMed ID: 24406129
    [Abstract] [Full Text] [Related]

  • 19. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF, Serrano-Gotarredona J, García-Robles R, Sancho J, Varela C.
    Metabolism; 1997 Aug 14; 46(8):902-7. PubMed ID: 9258272
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women.
    Stanczyk FZ, Slater CC, Ramos DE, Azen C, Cherala G, Hakala C, Abraham G, Roy S.
    Menopause; 2009 Aug 14; 16(2):272-8. PubMed ID: 19098687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 177.